Eylward Susan's Form 4 filing
Imunon, Inc.IMNN · filed Jun 29, 2026
- Accession no.
- 0001437749-26-022008
- Filed
- Jun 29, 2026
- Trade date
- Jun 25-29, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $20.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eylward SusanCIK 0002039135 | Officer (General Counsel and Corp Sec) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Common Stock | AGrant or awardAcquired | +14,696 | $1.72 | +$25,277.12 | 14,696 | Direct | |
| Jun 29, 2026 | Common Stock | SSaleDisposed | −11,800 | $1.75F2 | −$20,650 | 2,896 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Reflects a weighted average sale price of $1.752 per share, at prices ranging from $1.73 to $1.80 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.